About this trial
This is a prospective study of patients undergoing EUS procedures using the RIVOS™ EUS access device.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 18 years
All patients undergoing EUS-guided interventions using the RIVOS™ EUS access device
Disqualifiers
Age < 18 years
Patients who did not undergo EUS-guided interventions using the RIVOS™ EUS access device
Trial population
Patients undergoing EUS-guided interventions
Trial design
Cohort
Prospective
Treatments tested in this trial
EUS-guided intervention using the RIVOS™ EUS access device
DeviceEUS-guided intervention using the RIVOS™ EUS access device
Treatment groups
Trial outcomes
Primary outcomes
Technical success
Rate of technical success in patients undergoing EUS-guided procedures
Secondary outcomes
Treatment success
Rate of treatment success, defined as the resolution of symptoms and/or radiological findings from underlying disease at 4-weeks following index intervention.
Adverse events
Rate of adverse events, procedure-related and disease-related, in patients undergoing endoscopic ultrasound procedures.
Procedure duration
Total procedure duration, defined as time taken from start of the EUS-procedure to time the echoendoscope is withdrawn from the patient.
Hospital admission
Rate of hospital admission due to disease-related symptoms or procedure-related adverse events.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.